• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Wellbeing Digital Sciences Inc (OP: KONEF )

    N/A UNCHANGED
    Last Price Updated: 3:57 PM EST, Mar 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Wellbeing Digital Sciences Inc

    < Previous 1 2 3 Next >
    World's Largest Psychedelics Conference Sheds Light On Alternative Mental Health Therapies, Boasts 12K Attendees
    The Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored a Psychedelic Science conference in Denver last week, which gathered over 12,000 people from the entire psy 
    Via Benzinga
    Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Digital Enters into Share Purchase Agreement with Cardinal Group
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Announces Cease Trade Order
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Provides Bi-Weekly Default Status Report
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Digital to Participate at the Benzinga Psychedelic Capital Conference
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
    Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial 
    Via Benzinga
    Wellbeing Digital to Participate at the Cantor Fitzgerald Virtual Panel Discussion
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Another Company Approved To Begin Production Of Psychedelics Under Canadian Dealers License
    A Contract Research Organization (CRO) and a wholly-owned subsidiary of Wellbeing Digital Sciences Inc. 
    Via Benzinga
    Wellbeing Digital to Participate in The Global Biomedical Design Conference
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person
    This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established... 
    Via Benzinga
    Wellbeing Subsidiary KGK Science Applies for a Controlled Substances Dealers License and Receives Approval to Proceed with Buildout
    From WELLBEING DIGITAL SCIENCES
    Via Business Wire
    Wellbeing Provides Bi-Weekly Default Status Report
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Digital to Participate in MarigoldLIVE: International Women’s Day Networking Event
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
    Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and... 
    Via Benzinga
    Wellbeing Provides Bi-Weekly Default Status Report
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Subsidiary KGK Science Announces Publication of Safety Studies on Paraxanthine and Comparison to Caffeine Toxicity.
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
    Wellbeing Digital (OTC: KONEF) subsidiary KGK Sciences will advance with the first-ever Phase 2a clinical trial assessing repetitive, oral microdose psilocybin therapy for Fragile X Syndrome (FXS), a... 
    Via Benzinga
    Wellbeing Subsidiary KGK Science Receives Exemption Under Section 56 of the Controlled Drugs and Substances Act to Begin Psilocybin Clinical Trial
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Announces Delay in Filing Its Financial Statements and Management Cease Trade Order
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Women's Footprint In Psychedelics Is Undeniable, Benzinga's Psychedelics Advisory Council's Six New Trailblazers
    In its capacity as a financial news and media outlet, Benzinga has added six new members to its Psychedelics Advisory Council. 
    Via Benzinga
    Wellbeing Digital to Participate in the Psychedelic Medicine Association Webinar
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Digital Announces Change of Auditor
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
    The partnership leading the way on psilocybin therapy for Fragile X Syndrome (FXS), the major genetic cause of Autism Spectrum Disorder (ASD), has received approval from Health Canada in the form of a... 
    Via Benzinga
    Wellbeing Subsidiary KGK Science Receives Approval for First-of-its-Kind Psylocibin Clinical Trial
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    Wellbeing Subsidiary KGK Science Awarded Cannabis Research License from Health Canada
    From Wellbeing Digital Sciences Inc.
    Via Business Wire
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.